Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 341

1.

Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasis.

Maher VM, Kitano Y, Neuwirth C, Davies GJ, Maseri A, Thompson GR, Andreotti F.

J Thromb Thrombolysis. 2009 Aug;28(2):166-72. doi: 10.1007/s11239-008-0260-8. Epub 2008 Jul 30.

PMID:
18665328
[PubMed - indexed for MEDLINE]
2.

Changes in lipoprotein(a), LDL-cholesterol and apolipoprotein B in homozygous familial hypercholesterolaemic patients treated with dextran sulfate LDL-apheresis.

Lasunción MA, Teruel JL, Alvarez JJ, Carrero P, Ortuño J, Gómez-Coronado D.

Eur J Clin Invest. 1993 Dec;23(12):819-26.

PMID:
8143758
[PubMed - indexed for MEDLINE]
3.

Hemostatic variables in homozygous familial hypercholesterolemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis.

Di Minno G, Cerbone AM, Cirillo F, Postiglione A, Colucci M, Semeraro N, Scarpato N, Gnasso A, Margaglione M, Gallotta G, et al.

Arteriosclerosis. 1990 Nov-Dec;10(6):1119-26.

PMID:
2123091
[PubMed - indexed for MEDLINE]
Free Article
4.

Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100.

Maher VM, Kitano Y, Neuwirth C, Gallagher JJ, Thompson GR, Myant NB.

Atherosclerosis. 1992 Aug;95(2-3):231-4.

PMID:
1418096
[PubMed - indexed for MEDLINE]
5.

Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.

Koizumi J, Koizumi I, Uno Y, Inazu A, Kajinami K, Haraki T, Yagi K, Kamon N, Miyamoto S, Takegoshi T, et al.

Atherosclerosis. 1993 Apr;100(1):65-74.

PMID:
8318064
[PubMed - indexed for MEDLINE]
6.

Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis.

Donner MG, Parhofer KG, Richter WO, Schwandt P.

Metabolism. 1999 Jul;48(7):881-6.

PMID:
10421230
[PubMed - indexed for MEDLINE]
7.

Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy.

Pfohl M, Naoumova RP, Klass C, Knisel W, Jakober B, Risler T, Thompson GR.

J Lipid Res. 1994 Nov;35(11):1946-55.

PMID:
7868973
[PubMed - indexed for MEDLINE]
Free Article
8.

Predictability of low-density lipoprotein levels during apheretic treatment of hypercholesterolaemia.

Franceschini G, Busnach G, Calabresi L, Chiesa G, Gianfranceschi G, Zoppi F, Minetti L, Sirtori CR.

Eur J Clin Invest. 1991 Apr;21(2):209-14.

PMID:
1905633
[PubMed - indexed for MEDLINE]
9.

Extracorporeal treatment of hypercholesterolaemia.

Olbricht CJ.

Nephrol Dial Transplant. 1993;8(9):814-20.

PMID:
8255513
[PubMed - indexed for MEDLINE]
10.

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).

Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M.

Atherosclerosis. 1987 Nov;68(1-2):19-25.

PMID:
2446636
[PubMed - indexed for MEDLINE]
11.

Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.

Leitinger N, Pirich C, Blazek I, Endler G, Sinzinger H.

Atherosclerosis. 1996 Oct 25;126(2):305-12.

PMID:
8902156
[PubMed - indexed for MEDLINE]
12.

Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemia.

Okopien B, Cwalina L, Lebek M, Kowalski J, Zielinski M, Wisniewska-Wanat M, Kalina Z, Herman ZS.

Int J Clin Pharmacol Ther. 2001 Dec;39(12):551-7.

PMID:
11770837
[PubMed - indexed for MEDLINE]
13.

Hematologic and hemostatic changes induced by different columns during LDL apheresis.

Hovland A, Hardersen R, Nielsen EW, Mollnes TE, Lappegård KT.

J Clin Apher. 2010;25(5):294-300. doi: 10.1002/jca.20256.

PMID:
20806414
[PubMed - indexed for MEDLINE]
14.

Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia.

Rubba P, Faccenda F, Di Somma S, Gnasso A, Scarpato N, Iannuzzi A, Nappi G, Postiglione A, De Divitiis O, Mancini M.

Stroke. 1993 Aug;24(8):1154-61.

PMID:
8342189
[PubMed - indexed for MEDLINE]
Free Article
15.

[Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns].

Delplanque B, Emmerich J, Norol F, Jourdan D, Duedari N, Jacotot B.

Ann Med Interne (Paris). 1988;139 Suppl 1:80-2. French.

PMID:
2470282
[PubMed - indexed for MEDLINE]
16.

Efficacy of different low-density lipoprotein apheresis methods.

Parhofer KG, Geiss HC, Schwandt P.

Ther Apher. 2000 Oct;4(5):382-5.

PMID:
11111821
[PubMed - indexed for MEDLINE]
17.

Effects of LDL apheresis on blood rheology in two patients with homozygous familial hypercholesterolaemia.

Fadul JE, Sandhagen B, Linde T, Vessby B, Wikström B, Danielson BG.

Blood Purif. 1997;15(3):182-7.

PMID:
9262844
[PubMed - indexed for MEDLINE]
18.

Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.

Mol MJ, Stalenhoef AF.

Neth J Med. 1990 Jun;36(5-6):279-87.

PMID:
2395495
[PubMed - indexed for MEDLINE]
19.

Treatment of homozygous and double heterozygous familial hypercholesterolemic children with LDL-apheresis.

Stefanutti C, Vivenzio A, Colombo C, Di Giacomo S, Mazzarella B, Berni A, Nigri A, Koga N.

Int J Artif Organs. 1995 Feb;18(2):103-10.

PMID:
7558394
[PubMed - indexed for MEDLINE]
20.

[Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].

Bláha V, Havel E, Zadák Z, Pidrman V, Bláha M, Kalinová M.

Vnitr Lek. 1995 Oct;41(10):724-9. Review. Czech.

PMID:
8578708
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk